Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI-guided remifentanil administration during functional endoscopic sinus surgery
ChiCTR-IPR-17010381Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nantong University
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in perioperative pain and acute postoperative pain (2 arms), sponsored by The Second Affiliated Hospital of Nantong University. Primary endpoints: Intraoperative remifentanil consumption, Awaken time and 2 more. Planned start Feb 2017; status: not yet recruiting.
02
Drugs
remifentanil
03
Conditions
perioperative painacute postoperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-17010381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010381.